Page last updated: 2024-10-30

loxoprofen and Osteoarthritis

loxoprofen has been researched along with Osteoarthritis in 3 studies

loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.

Osteoarthritis: A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.

Research Excerpts

ExcerptRelevanceReference
"Non-steroidal anti-inflammatory drugs (NSAIDs) are an effective and common treatment for chronic pain disorders, but long-term use is associated with risk of potentially life-threatening gastrointestinal adverse events (AEs)."2.78Safety and efficacy of long-term esomeprazole 20 mg in Japanese patients with a history of peptic ulcer receiving daily non-steroidal anti-inflammatory drugs. ( Kinoshita, Y; Miwa, H; Sugano, K; Takeuchi, T, 2013)
"Knee pain was assessed by weight distribution on the hind paw, and cartilage damage and MMP production in the joints were evaluated 18 days after surgery."1.36High molecular weight hyaluronic acid relieved joint pain and prevented the progression of cartilage degeneration in a rabbit osteoarthritis model after onset of arthritis. ( Hashizume, M; Koike, N; Mihara, M; Suzuki, M; Yoshida, H, 2010)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Guo, Q1
Liu, Z1
Wang, M1
Guo, S1
Cong, H1
Liu, L1
Sugano, K1
Kinoshita, Y1
Miwa, H1
Takeuchi, T1
Hashizume, M1
Koike, N1
Yoshida, H1
Suzuki, M1
Mihara, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Long Term Study to Investigate the Efficacy and Safety Study of D961H (Esomeprazole) (20 mg Once Daily) for the Prevention of Gastric and/or Duodenal Ulcers Associated With Daily Nonsteroidal Anti-inflammatory Drug (NSAID) Use[NCT00595517]Phase 3395 participants (Actual)Interventional2007-10-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Participants Without Gastric and/or Duodenal Ulcer Throughout the Treatment Period

(NCT00595517)
Timeframe: up to 52 weeks

InterventionParticipants (Number)
Esomeprazole 20mg125

Number of Participants Without Gastric and/or Duodenal Ulcer up to 12 Weeks After Treatment

(NCT00595517)
Timeframe: up to 12 weeks after treatment

Interventionparticipants (Number)
Esomeprazole 20mg127

Number of Participants Without Gastric and/or Duodenal Ulcer up to 24 Weeks After Treatment

(NCT00595517)
Timeframe: up to 24 weeks after treatment

Interventionparticipants (Number)
Esomeprazole 20mg126

Number of Participants Without Gastric and/or Duodenal Ulcer up to 4 Weeks After Treatment

(NCT00595517)
Timeframe: up to 4 weeks after treatment

InterventionParticipants (Number)
Esomeprazole 20mg130

Trials

1 trial available for loxoprofen and Osteoarthritis

ArticleYear
Safety and efficacy of long-term esomeprazole 20 mg in Japanese patients with a history of peptic ulcer receiving daily non-steroidal anti-inflammatory drugs.
    BMC gastroenterology, 2013, Mar-26, Volume: 13

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Esomeprazole; Fema

2013

Other Studies

2 other studies available for loxoprofen and Osteoarthritis

ArticleYear
Analysis on the expression and value of CCL2 and CCL3 in patients with osteoarthritis.
    Experimental and molecular pathology, 2021, Volume: 118

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Biomarkers; Chemokine CCL

2021
High molecular weight hyaluronic acid relieved joint pain and prevented the progression of cartilage degeneration in a rabbit osteoarthritis model after onset of arthritis.
    Modern rheumatology, 2010, Volume: 20, Issue:5

    Topics: Adjuvants, Immunologic; Analgesics; Animals; Animals, Inbred Strains; Anti-Inflammatory Agents, Non-

2010